News

29th Symposium on Glycosaminoglycans – September 12th – 14th The annual Glycosaminoglycan Symposium will take place on San Servolo Island, in Venice Lagoon. Eminent specialists from all over the world...

Enisamium inhibits SARS-CoV-2 RNA synthesis. Stefano Elli, Denisa Bojkova, Marco Bechtel, Thomas Vial, David Boltz, Miguel Muzzio, Xinjian Peng, Federico Sala, Cesare Cosentino, Andrew Goy, Marco Guerrini, Lutz Muller *,...

28th Symposium on Glycosaminoglycans – September 27th – 29th Following the interruption last year due to the pandemic, the series of annual Symposia resumes with the 28th edition, which will...

Istituto G. Ronzoni contributed to the ACS spring meeting, the virtual event from 5th to 30th April 2021, organized by the American Chemical Society.Watch our contribution on less known aspects...

Ronzoni Institute contribution to the Virtual edition of Milan Polymer Days congress: “MD simulation of the interaction between neuraminidase N1 of the 1918 pandemic influenza virus to sialoglycan”

Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the spike S1 receptor-binding domain with heparin.   https://www.youtube.com/watch?v=dDnQDvnTMd4

As for the past editions, the Glycosaminoglycan Symposium is organized in collaboration with the University of Heidelberg/Mannheim (Prof. J. Harenberg) and will take place in Villa Vigoni (Loveno, Lake Como)

November 23rd, 2017  “Aula Maggiore”, Facoltà di Agraria, Università degli studi di Milano (programma pdf)

Glycol-split non-anticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo . Maura Poli, Michela Asperti, Annamaria Naggi, Natascia Campostrini, Domenico Girelli, Michela Corbella, Marina Benzi, Celine Besson-Fournier,...